Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β

Nature Immunology

Volumn 2, Issue 3, 2001, Pages 242-247

  Kee, Barbara L ^a   Rivera, Richard R ^a   Murre, Cornelis ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; ID3 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION PROTEIN; TCF3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; RETROVIRUS; STEM CELL; TRANSACTIVATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; INHIBITOR OF DIFFERENTIATION PROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; RETROVIRIDAE; STEM CELLS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0035289643     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/85303     Document Type: Article

References (52)

1. Murre, C. et al. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta 1218, 129-135 (1994).
2. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59 (1990).
3. Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 (1987).
4. Lee, J. E. et al. Conversion of Xenopus ectoderm into neruons by NeuroD, a basic helix-loop-helix protein. Science 268, 836-844 (1995).
5. Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885-892 (1994).
6. Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875-884 (1994).
7. Sun, X.-H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893-900 (1994).
8. Heemskerk, M. H. M. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597-1602 (1997).
9. Bain, G. et al. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782-4791 (1997).
10. Yan, W. et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317-7327 (1997).
11. Zhuang, Y., Cheng, P. & Weintraub, H. B-Lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16, 2898-2905 (1996).
12. Lee, G., Namen, A. E., Gillis, S., Ellingsworth, L. R. & Kincade, P. W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J. Immunol. 142, 3875-3883 (1989).
13. Chantry, D., Turner, M. & Feldmann, M. Interleukin 7 (murine pre-B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: regulation by transforming growth factor β. Eur. J. Immunol. 19, 783-786 (1989).
14. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
15. Kulkarni, A. B. et al. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 90, 770-774 (1993).
16. Yaswen, L. et al. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood 87, 1439-1445 (1996).
17. Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181 (2000).
18. Cazac, B. B. & Roes, J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13, 443-451 (2000).
19. Saltzman, A. et al. Transforming growth factor-β-mediated apoptosis in the Ramos B-Lymphom cell line is accompanied by caspase activation and Bcl-xL downregulation. Exp. Cell Res. 242, 244-254 (1998).
20. Buske, C. et al. TGF-β and its receptor complex in leukemic B-cell precursors. Exp. Hematol. 26, 1155-1161 (1993).
21. Lotz, M., Ranheim, E. & Kipps, T. J. Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med. 179, 999-1004 (1994).
22. Douglas, R. S., Capocasle, R. J., Lamb, R. J., Nowell, P. C. & Moore, J. S. Chronic lymphocytic leukemia B cell are resistant to the apoptotic effects of transforming growth factor-β. Blood 89, 941-947 (1997).
23. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90, 8392-8396 (1993).
24. Quong, M. W., Harris, D. R. Swain, S. L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307-6318 (1999).
25. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Meth. 184, 39-51 (1995).
26. Salvesen, G. S. & Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell 91, 443-446 (1997).
27. Whitman, M. Smads and early developmental signaling by the TGFβ superfamily. Genes Dev. 12, 2445-2462 (1998).
28. Arsura, M., Wu, M. & Sonenshein, G. E. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional actiation of IκBα. Immunity 5, 31-40 (1996).
29. Schlissel, M., Voronova, A. & Baltimore, D. Helix-loop-helix transcription factor E47 activates germline immunoglobulin heavy-chain transcription and rearrangement in a pre-T-cell line. Genes Dev. 5, 1367-1376 (1991).
30. Kee, B. L. & Murre, C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188, 699-713 (1998).
31. Lasorella, A., Noseda, M., Beyna, M. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by myc oncoproteins. Nature 407, 592-598 (2000).
32. Massague, J. TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791 (1998).
33. Baker, J. C. & Harland, R. M. From receptor to nucleus: the Smad pathway. Curr. Opin. Gen. Dev. 7, 467-473 (1997).
34. Nakao, A. et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631-635 (1997).
35. Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173 (1997).
36. Lo, R. S. & Massague, J. Ubiquitin-dependent degradation of TGF-β-activated Smad2. Nature Cell Biol. 1, 472-478 (1999).
37. Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nature Immunol. 2, 165-171 (2001).
38. Kpl induces cell migration. Nature Med. 4, 1449-1452 (1998).
39. Rivera, R. R., Johns, C. P., Quan, J., Johnson, R. S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17-26 (2000).
40. Pan, L. Sato, S. Frederick, J P., Sun, X.-H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19, 5969-5980 (1999).
41. Miyazaki, M. et al. Transforming growth factor-β1 stimulates or inhibits cell growth via down- or upregulation of p21/Waf1. Biochem. Biophy. Res. Comm. 246, 873-880 (1998).
42. Kpl mRNA and protein in murine B cells. J. Immunol. 160, 770-777 (1998).
43. Kpl cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEH1 231 B cells. J. Immunol. 163, 6530-6535 (1999).
44. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
45. Ink4b pathway. Mol. Cell. Biol. 19, 5913-5922 (1999).
46. Hollnagel, A., Oehlmann, V., Heymer, J., Ulrich, R. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845 (1999).
47. Heath, V. L., Murphy, E. E., Crain, C., Tomlinson, M. G. & O'Garra, A. TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30, 2639-2649 (2000).
48. Gorelik, L., Fields, P. E. & Flavell, R. A. TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165, 4773-4777 (2000).
49. Kee, B. L., Quong, M. W. & Murre, C. E2A proteins: Essential regulators at multiple stages of B-cell development. Immunol. Rev. 175, 138-149 (2000).
50. Bain, G., Quong, M. W., Soloff, R. S., Hedrick, S. M. & Murre, C. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190, 1605-1616 (1999).
51. Engel, I. & Murre, C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl Acad. Sci. USA 96, 996-1001 (1999).
52. Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145-154 (1997).